Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

RecruitingOBSERVATIONAL
Enrollment

5,950

Participants

Timeline

Start Date

March 12, 1998

Conditions
Malignant NeoplasmsHereditary Neoplastic SyndromesKidney CancerRenal CancerBladder Cancer
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00026884 - Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease | Biotech Hunter | Biotech Hunter